Dr. Berard received her PhD in Medical Microbiology in 2015 through the University of Manitoba, where she studied the differences in proteomic expression in viral infections, performing a systems biology approach to study host-pathogenic interactions. During her post-doctoral work, Dr. Berard studied mucosal biology in the context of HIV infection to determine mechanisms of pathogenesis and increased acquisition using similar systems biology approaches, SIV macaque models, co-culture, and vaginal epithelial barrier models. As a Research Associate, she is studying how the microbiome affects female reproductive health using multi-omic approaches including metaproteomics, metabolomics, transcriptomics, and flow cytometry, as well as multiple experimental bacterial co-culture assays to test mechanisms of barrier dysfunction. She is currently co-leading the THRIVE BV study (“The Study of Host-bacterial Relationships and Immune function in different Vaginal Environments”), to prospectively investigate the kinetics and specific host, immune, and microbiome factors that lead to recurrent bacterial vaginosis (BV) in women.
Dr. Berard received her PhD in Medical Microbiology in 2015 through the University of Manitoba, where she studied the differences in proteomic expression in viral infections, performing a systems biology approach to study host-pathogenic interactions. During her post-doctoral work, Dr. Berard studied mucosal biology in the context of HIV infection to determine mechanisms of pathogenesis and increased acquisition using similar systems biology approaches, SIV macaque models, co-culture, and vaginal epithelial barrier models. As a Research Associate, she is studying how the microbiome affects female reproductive health using multi-omic approaches including metaproteomics, metabolomics, transcriptomics, and flow cytometry, as well as multiple experimental bacterial co-culture assays to test mechanisms of barrier dysfunction. She is currently co-leading the THRIVE BV study (“The Study of Host-bacterial Relationships and Immune function in different Vaginal Environments”), to prospectively investigate the kinetics and specific host, immune, and microbiome factors that lead to recurrent bacterial vaginosis (BV) in women.